The Big Beautiful Bill Signals Congress Taking the Wheel on U.S.–China Trade

Unlike the promised “90 deals in 90 days”, President Trump did deliver on the domestic front—on time, and on message. The One Big Beautiful Bill, signed into law on Independence Day, fulfilled key MAGA priorities and Trump’s campaign promises: sweeping tax cuts, stricter immigration enforcement, and a broad rollback of Biden-era progressive agendas, including some of the climate provisions in the Inflation Reduction Act. It also added $3.4 trillion to the national deficit, justified by projected tariff revenues whose collection mechanisms remain more aspirational than real.

But the bill’s significance doesn’t end at America’s borders. Tucked within its hundreds of pages are provisions that quietly restructure the foundations of U.S.–China economic relations. In doing so, it signals that trade policy between Washington and Beijing may no longer hinge on who occupies the White House or what tone diplomacy sets, but on how Congress rewrites the rules of the economic game—often in the name of domestic renewal.

A prime example is the bill’s repeal of the long-standing de minimis exemption, which currently allows goods valued under $800 to enter the United States duty-free. For years, this provision has facilitated the entry of low-value manufactured goods—particularly textiles, consumer electronics, and household products—into the U.S. market, many of them originating from China. While often portrayed in Washington as a regulatory gap, de minimis has functioned in practice as a conduit for price-sensitive imports that serve U.S. consumer demand in product categories where domestic production capacity is limited or not cost-efficient. Yet in the political arena, it has become an increasingly convenient target. For lawmakers seeking to project support for American manufacturing and blue-collar jobs—especially in swing-state industrial bases—de minimis represents both a symbolic and statistical vulnerability. It also aligns with the broader bipartisan anxiety about overreliance on Chinese supply chains, making it an expedient policy lever in an age of economic security framing. 

Ending this practice has been a rhetorical priority for both parties, but attempts at executive enforcement have fallen short in practice. In April 2025, President Trump announced a unilateral order to suspend de minimis exemptions for Chinese imports, framing the move as a crackdown on fentanyl-related supply chains and reciprocal treatment for China’s alleged unfair treatments. Yet within weeks, the effort was quickly shelved, reportedly due to logistical complications, lack of agency coordination, and opposition from major retailers. What the White House could not enforce, Congress simply legislated: the Beautiful Bill locks in the full repeal of de minimis by July 2027, this time as a statutory mandate—not executive improvisation.

The repeal is not an isolated case. It is part of a broader shift in 2025 toward a legislative architecture designed to constrain executive discretion and institutionalize long-term economic competition with China. The Beautiful Bill itself plays a central role in this process—not only through its explicit provisions, but also through its fiscal structure. By establishing aggressive tax cuts and capping non-defense discretionary spending through 2028, the bill sharply reduces the flexibility available to the executive branch for overseas financing, development cooperation, or market stabilization tools that have historically enabled ad hoc engagement with Beijing. In this sense, it doesn’t merely close the de minimis door—it narrows the entire hallway of economic diplomacy.

This structural narrowing has been mirrored in the legislative tempo of the 119th Congress. From the introduction of the U.S. Supply Chain Security and Resilience Act, which mandates procurement restrictions on Chinese-origin critical inputs, to the bundled legislative package on outbound investment—including the reintroduction of the belligerent sounded FIGHT China Act, and the appallingly named- and even more appallingly drafted – STOP CCP Act – Congress has shown more than just intention to construct a framework that will almost certainly outlast the second Trump administration. The trendline is clear: economic decoupling is no longer a matter of regulatory discretion; it is being written into law.

That also means the Trump administration’s room to direct—or at least amend—its approach to China is already constrained—if they ever want to, that is. The tough fight to pass the Big Beautiful Bill by a narrow edge has already revealed the limits of the administration’s ability to push through additional major legislation, even at the height of the president’s second-term momentum. That vote was not just about disagreement over budget lines—it marked the outer edge of what the current MAGA–GOP coalition is willing to do, and exposed the transactional fragility of congressional alignment behind Trump.

Looking ahead, any future re-engagement with Beijing—or tactical maneuvering on trade, technology, or capital—cannot risk frustrating the Hill. And between now and the 2026 midterms, when every House member will face reelection and “being tough on China” remains a politically essential posture, such buy-in is likely to be in short supply. Nor will things ease once the new Congress is sworn in: newly elected lawmakers will have every incentive to mark their arrival with loud, visible action on China—not subtle course corrections. Even if the White House wants flexibility, it may soon find itself legislatively boxed in, with the steering wheel visible—but not attached.

The congressional push to take control over U.S. trade and competition policy with China has not stopped at legislation. Not to mention the diligently competing Select Committee on the CCP, throughout the first half of this year, hearings held by committees not traditionally focused on China—ranging from commerce and small business to energy and financial services—have also increasingly treated economic engagement with Beijing as a structural risk to national resilience. Concepts like “strategic dependency” and “supply chain sovereignty” are no longer abstract critiques; they are steadily migrating into committee hearings and statutory language.

For years, policymakers and analysts alike have leaned on a comforting metaphor: that trade and investment ties could serve as a “ballast” to keep the U.S.–China relationship steady even as storms gathered elsewhere. That ballast has now cracked. And the ship is drifting—not because of any dramatic diplomatic rupture, but because the very architecture of bilateral stability is being quietly dismantled through domestic legislation and long-term structural constraints.

The repeal of de minimis may be just one element of the broader institutional reset now underway in U.S.–China relations. But what this means for Beijing is clear: there is no going back to a time when economic pragmatism could override political antagonism. The idea that trade can once again anchor bilateral relations is no longer sustainable. If stabilization is to be achieved, it will have to come through channels yet unknown—because the familiar mechanics of trade and capital diplomacy no longer apply.

The Big Beautiful Bill may have been signed as domestic legislation, but its effects will not stop at the water’s edge.